| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net revenues | $11.04B+11.8% | $9.87B+6.7% | $9.25B-6.4% | $9.88B-8.4% | $10.79B+14.3% | $9.44B+22.1% | $7.73B+2.6% | $7.53B+1.7% | $7.40B |
| Cost of services | $7.37B+11.2% | $6.63B+6.9% | $6.20B-3.9% | $6.45B-2.0% | $6.58B+13.4% | $5.80B+15.2% | $5.04B+2.3% | $4.93B+4.4% | $4.72B |
| Selling, general and administrative | $1.97B+11.1% | $1.77B+7.8% | $1.64B-12.4% | $1.87B+8.5% | $1.73B+11.4% | $1.55B+6.4% | $1.46B+2.3% | $1.42B-1.3% | $1.44B |
| Amortization of intangible assets | $154.0M+21.3% | $127.0M+17.6% | $108.0M-10.0% | $120.0M+16.5% | $103.0M+0.0% | $103.0M+7.3% | $96.0M+6.7% | $90.0M+21.6% | $74.0M |
| Other operating (income) expense, net | -$12.0M-1300.0% | $1.0M-97.6% | $41.0M+272.7% | $11.0M+650.0% | -$2.0M-122.2% | $9.0M+109.5% | -$95.0M-850.0% | -$10.0M-1100.0% | $1.0M |
| Total operating costs and expenses, net | $9.48B+11.2% | $8.53B+6.7% | $7.99B-5.5% | $8.46B+0.6% | $8.41B+12.6% | $7.47B+14.9% | $6.50B+1.0% | $6.43B+3.1% | $6.24B |
| Operating income | $1.56B+15.6% | $1.35B+6.7% | $1.26B-11.6% | $1.43B-40.0% | $2.38B+20.8% | $1.97B+60.1% | $1.23B+11.8% | $1.10B-5.5% | $1.17B |
| Interest expense, net | -$264.0M-31.3% | -$201.0M-32.2% | -$152.0M-10.1% | -$138.0M+8.6% | -$151.0M+7.4% | -$163.0M+6.9% | -$175.0M-4.8% | -$167.0M-10.6% | -$151.0M |
| Other Nonoperating Income (Expense) | $26.0M-13.3% | $30.0M+50.0% | $20.0M+136.4% | -$55.0M-114.9% | $369.0M+385.5% | $76.0M+280.0% | $20.0M+350.0% | -$8.0M-150.0% | $16.0M |
| Total non-operating expense, net | -$238.0M-39.2% | -$171.0M-29.5% | -$132.0M+31.6% | -$193.0M-188.5% | $218.0M+350.6% | -$87.0M+43.9% | -$155.0M+11.4% | -$175.0M-29.6% | -$135.0M |
| Income before income taxes and equity in earnings of equity method investees | $1.32B+12.2% | $1.18B+4.0% | $1.13B-8.5% | $1.24B-52.5% | $2.60B+38.0% | $1.88B+75.1% | $1.08B+16.2% | $926.0M-10.1% | $1.03B |
| Income tax expense | -$314.0M-15.0% | -$273.0M-10.1% | -$248.0M+6.1% | -$264.0M+55.8% | -$597.0M-29.8% | -$460.0M-86.2% | -$247.0M-35.7% | -$182.0M+24.5% | -$241.0M |
| Equity in earnings of equity method investees, net of taxes | $42.0M+121.1% | $19.0M-26.9% | $26.0M-40.9% | $44.0M-43.6% | $78.0M+4.0% | $75.0M+31.6% | $57.0M+29.5% | $44.0M+25.7% | $35.0M |
| Net income | $1.05B+13.6% | $921.0M+1.4% | $908.0M-10.5% | $1.01B-51.2% | $2.08B+38.8% | $1.50B+65.5% | $906.0M+15.0% | $788.0M-4.4% | $824.0M |
| Less: Net income attributable to noncontrolling interests | $54.0M+8.0% | $50.0M-7.4% | $54.0M-21.7% | $69.0M-18.8% | $85.0M+25.0% | $68.0M+41.7% | $48.0M-7.7% | $52.0M+0.0% | $52.0M |
| Net income attributable to Quest Diagnostics | $992.0M+13.9% | $871.0M+2.0% | $854.0M-9.7% | $946.0M-52.6% | $2.00B+39.4% | $1.43B+66.8% | $858.0M+16.6% | $736.0M-4.7% | $772.0M |
| Basic (in dollars per share) | $8870000.00+14.0% | $7780000.00+2.5% | $7590000.00-6.3% | $8100000.00-48.9% | $15850000.00+49.2% | $10620000.00+67.0% | $6360000.00+18.0% | $5390000.00-4.3% | $5630000.00 |
| Diluted (in dollars per share) | $8750000.00+13.8% | $7690000.00+2.7% | $7490000.00-6.0% | $7970000.00-48.7% | $15550000.00+48.5% | $10470000.00+66.7% | $6280000.00+18.7% | $5290000.00-3.8% | $5500000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.